WILMINGTON – Seeking to supercharge its cancer drug pipeline, pharmaceutical giant AstraZeneca announced a deal potentially worth more than $1.2 billion to acquire a small California-based biotech firm working on lymphoma treatment. AstraZeneca, which has ...
CHRISTIANA – Bank of America announced Wednesday, Nov. 20, that it was donating $500,000 to the Endowed Fund for Translational Cancer Research at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute. The $10 million ...
John Haydon has put a face on the power of social media and on the willingness of pharmaceutical companies to support patients to deal with the high cost of their medications. Haydon, a leading expert ...
With more than 25 years of combined experience in the oncology-specialty home care sector, Meg Maley and Jill Teixeira, both oncology nurses and University of Delaware graduates, realized that patients and their families needed tools ...
WILMINGTON – The U. S Food and Drug Administration has granted approval to Lynparza, AstraZeneca and Merck’s PARP inhibitor for maintenance therapy for some ovarian cancer patients, according to the companies. PARP is a family ...
Premier Digital Partners
© 2022 Delaware Business Times
